Date: August 19, 2025
Author: Mousumi Islam,
Chairperson & Managing Director,
PROMIXCO GROUP — Health & Medical Advice
Executive Summary
This report frames how to quantify the total number of medical device products and product categories in the Bangladesh market. Exact counts change frequently as DGDA issues and renew registrations; therefore, we outline a reproducible method and provide the latest sources to compute an auditable total.
Key Facts
| Key Fact | Detail |
| Regulatory authority | Directorate General of Drug Administration (DGDA), Ministry of Health & Family Welfare |
| Regulatory risk classes | Class A (low) to Class D (high) |
| Market size (indicative) | ~USD 442m (2020) → ~USD 820m by 2025 (BIDA projection; import-dependent market) |
| Current registration regime | Marketing Authorization Certificate (MAC) required since 2023 |
Regulatory Classes (DGDA)
| Class | Risk Level |
| Class A | Low risk |
| Class B | Low–moderate risk |
| Class C | Moderate–high risk |
| Class D | High risk |
Market Product Segments (Benchmark)
– Consumables & Disposables
-Hospital Furniture
– Diagnostic Imaging
– Dental Products
– Orthopaedics & Prosthetics
– Patient Aids
– Other Medical Devices
Counting the Total Number of Products in Bangladesh
DGDA publishes an official ‘List of Registered Medical Devices’ (imported devices, Classes B–D). Download the latest PDF and count rows by unique product entries (Product name × Manufacturer × Importer × Class). We recommend maintaining a timestamped copy and an audit log of additions/removals.
References
– DGDA – Registered Medical Device List (Classes B–D, updated Jan 2025).
– Asia Actual – Bangladesh launches new medical device regulations (Oct 2023).
– BIDA – Medical Device investment sector (market projections).
– Fitch Solutions (BMI) – Medical Devices industry segmentation.
– Emerging Credit Rating – Medical Equipment Industry in Bangladesh (Nov 2023).
Disclaimer
For educational/informational purposes only. This is not medical, regulatory, or legal advice. Confirm requirements with DGDA and consult qualified professionals before making decisions.